<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02756468</url>
  </required_header>
  <id_info>
    <org_study_id>PREDIPS</org_study_id>
    <nct_id>NCT02756468</nct_id>
  </id_info>
  <brief_title>Procalcitonin Reveals Early Dehiscence in Pancreatic Surgery: the PREDIPS Study</brief_title>
  <acronym>PREDIPS</acronym>
  <official_title>Procalcitonin Reveals Early Dehiscence in Pancreatic Surgery: the PREDIPS Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Roma La Sapienza</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Roma La Sapienza</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background. Pancreatic cancer surgery is associated with very high risk of postoperative
      morbidity and mortality. Anastomotic leak (AL) is one of the worst complications associated
      with relevant short and long-term sequelae. Procalcitonin (PCT) is a biomarker used to
      monitor bacterial infections and guide antibiotic therapy and has been shown to have better
      predictive value of AL after colorectal surgery than C-reactive protein (CRP) and white blood
      cell count (WBC).

      Purpose. The investigators designed a monocentric pilot study to test if PCT might be a
      sensitive and reliable marker of AL after pancreatic surgery
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2015</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">June 2016</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>2 Years</target_duration>
  <primary_outcome>
    <measure>Sensitivity of PCT and CRP for anastomotic leak (AL) after pancreatic surgery</measure>
    <time_frame>2 yrs</time_frame>
    <description>Sensitivity: % of patients corrected identified by the biomarkers having AL; PCT: procalcitonin, CRP: C-reactive protein, AL: anastomic leak</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Specificity of PCT and CRP for anastomotic leak (AL) after pancreatic surgery</measure>
    <time_frame>2 yrs</time_frame>
    <description>Specificity: % of pts corrected identified by the biomarkers not having AL; PCT: procalcitonin, CRP: C-reactive protein, AL: anastomic leak</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>PCT and CRP cuts-off in 3rd POD with a good NPV for AL</measure>
    <time_frame>2 yrs</time_frame>
    <description>PCT: procalcitonin, CRP: C-reactive protein, NPV: negative predictive value</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PCT and CRP cuts-off in 5th POD with a good NPV for AL</measure>
    <time_frame>2 yrs</time_frame>
    <description>PCT: procalcitonin, CRP: C-reactive protein, NPV: negative predictive value</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Pancreatic Cancer</condition>
  <arm_group>
    <arm_group_label>pts operated for pancreatic cancer</arm_group_label>
    <description>all pts operated of pancreatic resection for cancer in the involved units</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>pts operated for pancreatic cancer</intervention_name>
    <description>measuring CRP and PCT in 3rd and 5th POD after pancreatic cancer resection</description>
    <arm_group_label>pts operated for pancreatic cancer</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        all pts undergoing pacreatic resections for cancer
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients undergoing all different kinds of pancreatic surgery

          -  in elective setting

          -  for cancer

          -  with a pancreatic anastomosis performed.

        Exclusion Criteria:

          -  age &lt; 18 years

          -  pregnant women

          -  patients undergoing pancreatic surgery for benign disease, other kinds of pancreatic
             surgery without an anastomosis being performed
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Valentina Giaccaglia, MD</last_name>
    <phone>+393397882429</phone>
    <email>v.giaccaglia@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Sant'Andrea University Hospital</name>
      <address>
        <city>Rome</city>
        <zip>00189</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Valentina Giaccaglia, MD</last_name>
      <phone>00393397882429</phone>
      <email>v.giaccaglia@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Valentina Giaccaglia, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>April 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 18, 2016</study_first_submitted>
  <study_first_submitted_qc>April 28, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 29, 2016</study_first_posted>
  <last_update_submitted>April 28, 2016</last_update_submitted>
  <last_update_submitted_qc>April 28, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 29, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Roma La Sapienza</investigator_affiliation>
    <investigator_full_name>Valentina Giaccaglia</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>pancreatic cancer</keyword>
  <keyword>procalcitonin</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancreatic Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Calcitonin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

